journal article·2024-10-12

Synthesis and characterization of nano-biopolymer carriers loaded with clove ( Syzygium aromaticum L.) extract as an anticancer agent: an in vitro study

Mehdi Ansari, Elmira Ravan Avard, Fariba Sharififar, Neda Mohamadi

Publisher page

Abstract

The objective of this work was to design a new drug nanoparticle (NP) composed of chitosan/β-cyclodextrin/sodium tripolyphosphate/alginate (CS/βCD/TPP/AL) loaded with a clove extract (CE) for potential anticancer effects. The extract was prepared by two extraction methods: hydroalcoholic maceration (MAC) with 80% MeOH and supercritical fluid (SCF). The MACCE and SCFCE CE NPs had particle sizes of 71 nm and 20 nm, respectively with irregular spherical shapes. The nanocarriers achieved entrapment efficiencies of over 90%. MACCE-NPs and SCFCE-NPs released 18.35% and 10.12% of the extract after 6 h, respectively. Cell viability decreased to 54%, 7%, and 12% in HeLa, U87, and KB cell lines, respectively, after a 48-hour treatment with SCFCE-NPs and 75%, 8%, and 17% after treatment with MACCE-NPs, significantly reduced compared to the control. It is concluded that NPs containing CE exhibit a higher degree of toxicity due to better penetration into cells.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Nanoparticle-Based Drug Delivery · Essential Oils and Antimicrobial Activity

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Drug and Food Control, Kerman University of Medical Sciences, Kerman, Iran

Herbal and Traditional Medicines Research Center, Kerman University of Medical Sciences, Kerman, Iran

Funding

Kerman University of Medical Sciences

References (49)

Show source-provided references
1. 10.3390/jfb1303012510.3390/jfb13030125 ↗
2. 10.3390/jfb1001000410.3390/jfb10010004 ↗
3. 10.4172/1747-0862.S4-00610.4172/1747-0862.S4-006 ↗
4. 10.2217/nnm-2020-036510.2217/nnm-2020-0365 ↗
5. 10.1016/j.molliq.2021.11765010.1016/j.molliq.2021.117650 ↗
6. 10.1155/2020/888609510.1155/2020/8886095 ↗
7. 10.1208/s12249-018-1278-710.1208/s12249-018-1278-7 ↗
8. Permatasari HK, Effendi AB, Qhabibi FR, et al. Eugenol isolated from Syzygium aromaticum inhibits HeLa cancer cell migration by altering epithelial-mesenchymal transition protein regulators. J Appl Pharm Sci. 2021;11(5):049–053.
9. 10.21776/ub.jkb.2019.030.03.410.21776/ub.jkb.2019.030.03.4 ↗
10. 10.3390/molecules2621638710.3390/molecules26216387 ↗
11. 10.3390/biom1002020210.3390/biom10020202 ↗
12. 10.1039/C7RA04803C10.1039/C7RA04803C ↗
13. 10.1155/2013/14632010.1155/2013/146320 ↗
14. 10.1021/bm301857710.1021/bm3018577 ↗
15. 10.1016/j.ijbiomac.2020.02.19110.1016/j.ijbiomac.2020.02.191 ↗
16. 10.1016/j.ijbiomac.2022.07.01810.1016/j.ijbiomac.2022.07.018 ↗
17. 10.1016/j.procbio.2022.06.03410.1016/j.procbio.2022.06.034 ↗
18. Noudeh GD, Sharififar F, Noodeh AD, et al. Antitumor and antibacterial activity of four fractions from Heracleum persicum Desf. and Cinnamomum zeylanicum Blume. J Med Plants Res. 2010;4(21):2176–2180.
19. 10.1515/znb-2005-111310.1515/znb-2005-1113 ↗
20. 10.1007/s40199-018-0211-710.1007/s40199-018-0211-7 ↗
21. 10.1186/s12906-022-03642-w10.1186/s12906-022-03642-w ↗
22. 10.1002/fsn3.148610.1002/fsn3.1486 ↗
23. 10.3923/pjbs.2012.49.5310.3923/pjbs.2012.49.53 ↗
24. 10.1016/j.mycmed.2016.06.00310.1016/j.mycmed.2016.06.003 ↗
25. 10.1111/j.1468-2494.2009.00503.x10.1111/j.1468-2494.2009.00503.x ↗
26. 10.1111/jfpp.1494610.1111/jfpp.14946 ↗
27. 10.1016/j.jmrt.2021.01.09810.1016/j.jmrt.2021.01.098 ↗
28. 10.1016/j.fpsl.2017.10.00510.1016/j.fpsl.2017.10.005 ↗
29. 10.3390/molecules2211197510.3390/molecules22111975 ↗
30. 10.1080/1071754059088978110.1080/10717540590889781 ↗
31. Farahani ZK. The effect of extraction method (ultrasonic, maceration and soxhlet) and solvent type on the extraction rate of phenolic compounds and extraction efficiency of Arctium lappa L. roots and Polygonum aviculare L. grass. Food Health J. 2021;4(2):28–34.
32. 10.1002/fsn3.289110.1002/fsn3.2891 ↗
33. 10.1002/wnan.151910.1002/wnan.1519 ↗
34. 10.3390/antiox1107135410.3390/antiox11071354 ↗
35. 10.1016/j.foodchem.2006.04.00910.1016/j.foodchem.2006.04.009 ↗
36. 10.1016/j.jcis.2017.01.06610.1016/j.jcis.2017.01.066 ↗
37. 10.1016/j.ijbiomac.2017.04.00210.1016/j.ijbiomac.2017.04.002 ↗
38. 10.1016/j.addr.2020.06.00710.1016/j.addr.2020.06.007 ↗
39. 10.1016/j.imu.2017.12.01010.1016/j.imu.2017.12.010 ↗
40. 10.1016/j.ijbiomac.2017.09.06510.1016/j.ijbiomac.2017.09.065 ↗
41. 10.1016/j.matchemphys.2021.12501910.1016/j.matchemphys.2021.125019 ↗
42. 10.1177/0883911523118348710.1177/08839115231183487 ↗
43. 10.1016/j.carres.2020.10818410.1016/j.carres.2020.108184 ↗
44. 10.34172/apb.2020.02210.34172/apb.2020.022 ↗
45. 10.1016/j.pestbp.2020.10474710.1016/j.pestbp.2020.104747 ↗
46. Elmoghayer ME, Saleh NM. Abu Hashim II. Enhanced oral delivery of hesperidin-loaded sulfobutylether-β-cyclodextrin/chitosan nanoparticles for augmenting its hypoglycemic activity: in vitro-in vivo assessment study. Drug Delivery Transl Res. 2023;14:1–23.
47. 10.1007/s13205-022-03117-210.1007/s13205-022-03117-2 ↗
48. 10.1111/jcmm.1780110.1111/jcmm.17801 ↗
49. 10.1111/jcmm.1831610.1111/jcmm.18316 ↗